Status:

COMPLETED

Fibromyalgia Health Outcome Study on Cost of Treatments

Lead Sponsor:

Eli Lilly and Company

Conditions:

Fibromyalgia

Eligibility:

All Genders

18+ years

Brief Summary

The Real World Examination of Fibromyalgia: Longitudinal Evaluation of Costs and Treatments (REFLECTIONS) Study is a 12-month, prospective observational study that will be utilized in approximately 58...

Eligibility Criteria

Inclusion

  • Meet criteria for fibromyalgia (FM) in the opinion of the investigator
  • Must be prescribed a 'new' treatment for FM
  • Male and female participants at least 18 years of age
  • Willing to complete the Informed Consent Document (ICD) and any other required forms to be eligible for study participation
  • Currently under the care of the participating physician
  • Cognitively able to understand and complete participant self-rated scales in English or Spanish via computer-assisted telephone interview (CATI)
  • Available for 12 months to participate in the study

Exclusion

  • Are investigator site personnel directly affiliated with the study and/or their immediate families. Immediate family is defined as a spouse, parent, child, or sibling, whether biological or legally adopted
  • Are Lilly employees
  • Are Terminally ill
  • Currently participating in other research studies or if beginning a research study while participating in this study
  • Unable to respond via telephone for CATI
  • Incompetent for interview as deemed by the participating physician
  • Unwilling to provide written ICD or other required forms to participate in the study

Key Trial Info

Start Date :

June 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2011

Estimated Enrollment :

1700 Patients enrolled

Trial Details

Trial ID

NCT00725101

Start Date

June 1 2008

End Date

April 1 2011

Last Update

November 30 2012

Active Locations (58)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 15 (58 locations)

1

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Hot Springs, Arkansas, United States, 71913

2

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Santa Barbara, California, United States, 93108

3

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Danbury, Connecticut, United States, 06810

4

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Waterbury, Connecticut, United States, 06708